Screening of colorectal cancer: present and future

References

• Global Burden of Disease Cancer Collaboration. The Global Burden of Cancer 2013. JAMA Oncol. 2015 Jul;1(4):505–527.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87.
   PubMed Web of Science ®Google Scholar
• Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide. [ cited Jul 2017]. Availble from: http://globocan.iarc.fr/Default.aspx
   Google Scholar
• Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594.
   PubMed Web of Science ®Google Scholar
• Kudo S, Tamura S, Hirota S, et al. The problem of de novo colorectal carcinoma. Eur J Cancer. 1995;31:1118–1120.
   Google Scholar
• Bettington M, Walker N, Clouston A, et al. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology. 2013;62:367–386.
   PubMed Web of Science ®Google Scholar
• Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759.
   PubMed Web of Science ®Google Scholar
• Saitoh Y, Waxman I, West AB, et al. Prevalence and distinctive biologic features of flat colorectal adenomas in a North American population. Gastroenterology. 2001;120:1657.
   PubMed Web of Science ®Google Scholar
• Rembacken BJ, Fujii T, Cairns A, et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet. 2000;355:1211.
   PubMed Web of Science ®Google Scholar
• Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977.
   PubMed Web of Science ®Google Scholar
• Cheng L, Eng C, Nieman LZ, et al. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol. 2011;34:573.
   PubMedGoogle Scholar
• Schub R, Steinheber FU. Rightward shift of colon cancer. A feature of the aging gut. J Clin Gastroenterol. 1986;8:630.
   PubMed Web of Science ®Google Scholar
• Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687–696.
   PubMed Web of Science ®Google Scholar
• Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med. 1993 May 13;328(19):1365–1371.
   PubMed Web of Science ®Google Scholar
• Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Gastroenterology. 2017 Jul;153(1):307–323.
   PubMed Web of Science ®Google Scholar
• Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104(3):739–750.
   PubMed Web of Science ®Google Scholar
• Lee BI, Hong SP, Kim SE, et al. Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc. 2012;45(1):25–43.
   PubMedGoogle Scholar
• European guidelines for quality assurance in colorectal cancer screening and diagnosis. [ cited Jul 2017]. Available from: http://www.kolorektum.cz/res/file/guidelines/CRC-screening-guidelines-EC-2011-02-03.pdf
   Google Scholar
• Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472–1477.
   PubMed Web of Science ®Google Scholar
• Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348(9040):1467–1471.
   PubMed Web of Science ®Google Scholar
• Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603–1607.
   PubMed Web of Science ®Google Scholar
• Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369(12):1106–1114.
   PubMed Web of Science ®Google Scholar
• Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103:1541–1549.
   PubMed Web of Science ®Google Scholar
• Heresbach D, Manfredi S, D’halluin PN, et al. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol. 2006 Apr;18(4):427–433.
   PubMed Web of Science ®Google Scholar
• Kerr J, Day P, Broadstock M, et al. Systematic review of the effectiveness of population screening for colorectal cancer. N Z Med J. 2007 Jul 20;120(1258):U2629.
   PubMedGoogle Scholar
• Pitkäniemi J, Seppä K, Hakama M, et al. Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland. BMJ Open Gastroenterol. 2015;2:e000034.
   PubMed Web of Science ®Google Scholar
• Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171.
   PubMed Web of Science ®Google Scholar
• Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 1996;334(3):155–159.
   PubMed Web of Science ®Google Scholar
• Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99(19):1462–1470.
   PubMedGoogle Scholar
• Cheng TI, Wong JM, Hong CF, et al. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc. 2002;101(10):685–690.
   PubMed Web of Science ®Google Scholar
• Nakama H, Yamamoto M, Kamijo N, et al. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology. 1999;46(25):228–231.
   PubMedGoogle Scholar
• Nakama H, Kamijo N, Abdul Fattah AS, et al. Validity of immunological faecal occult blood screening for colorectal cancer: a follow up study. J Med Screen. 1996;3(2):63–65.
   PubMedGoogle Scholar
• Parra-Blanco A, Gimeno-García AZ, Quintero E, et al. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol. 2010;45(7):703–712.
   PubMed Web of Science ®Google Scholar
• Chiu HM, Lee YC, Ch T, et al. Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test. Clin Gastroenterol Hepatol. 2013;11(7):832–8 e1-2.
   Web of Science ®Google Scholar
• Chiang TH, Lee YC, Tu CH, et al. Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract. CMAJ. 2011;183(13):1474–1481.
   PubMed Web of Science ®Google Scholar
• Sohn DK, Jeong SY, Choi HS, et al. Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat. 2005;37(1):20–23.
   PubMedGoogle Scholar
• Levi Z, Birkenfeld S, Vilkin A, et al. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. Int J Cancer. 2011;128(10):2415–2424.
   PubMed Web of Science ®Google Scholar
• Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146(4):244–255.
   PubMed Web of Science ®Google Scholar
• Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129(2):422–428.
   PubMed Web of Science ®Google Scholar
• Launoy GD, Bertrand HJ, Berchi C, et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer. 2005;115(3):493–496.
   PubMed Web of Science ®Google Scholar
• Itoh M, Takahashi K, Nishida H, et al. Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme. J Med Screen. 1996;3(2):66–71.
   PubMedGoogle Scholar
• Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105(9):2017–2025.
   PubMed Web of Science ®Google Scholar
• De Wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol. 2012;107(10):1570–1578.
   PubMed Web of Science ®Google Scholar
• Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer. 2013;49(14):3049–3054.
   PubMed Web of Science ®Google Scholar
• van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82–90.
   PubMed Web of Science ®Google Scholar
• Navarro M, Nicolas A, Ferrandez A, et al. Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol. 2017 May 28;23(20):3632–3642.
   PubMed Web of Science ®Google Scholar
• Grazzini G, Visioli CB, Zorzi M, et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?. Br J Cancer. 2009;100:259–265.
   PubMed Web of Science ®Google Scholar
• Katsoula A, Paschos P, Haidich AB, et al. Diagnostic accuracy of fecal immunochemical test in patients at increased risk for colorectal cancer: a meta-analysis. JAMA Intern Med. 2017 Aug 1;177(8):1110–1118.
   PubMed Web of Science ®Google Scholar
• Cai SR, Zhang SZ, Zhu HH, et al. Barriers to colorectal cancer screening: a case-control study. World J Gastroenterol. 2009;15:2531–2536.
   PubMed Web of Science ®Google Scholar
• Choi KS, Lee HY, Jun JK, et al. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004–2008. J Gastroenterol Hepatol. 2012;27:1070–1077.
   PubMed Web of Science ®Google Scholar
• Chiu HM, Chen SL, Yen AM, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer. 2015;121:3221–3229.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016;66:7–30.
   PubMed Web of Science ®Google Scholar
• Jensen CD, Corley DA, Quinn VP, et al. Fecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort study. Ann Intern Med. 2016;164:456–463.
   PubMed Web of Science ®Google Scholar
• Major D, Bryant H, Delaney M, et al. Colorectal cancer screening in Canada: results from the first round of screening for five provincial programs. Curr Oncol. 2013;20:252–257.
   PubMed Web of Science ®Google Scholar
• Sung JJ, Ng SC, Chan FK, et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2015;64:121–132.
   PubMed Web of Science ®Google Scholar
• Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut. 2015;64:1327–1337.
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287–1297.
   PubMed Web of Science ®Google Scholar
• Dhaliwal A, Vlachostergios PJ, Oikonomou KG, et al. Fecal DNA testing for colorectal cancer screening: molecular targets and perspectives. World J Gastrointest Oncol. 2015;7(10):178–183.
   PubMed Web of Science ®Google Scholar
• Binefa G, Rodríguez-Moranta F, Teule A, et al. Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol. 2014;20(22):6786–6808.
   PubMed Web of Science ®Google Scholar
• Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. JAMA. 2016;315(23):2595–2609.
   PubMed Web of Science ®Google Scholar
• Castells A, Bessa X, Quintero E, et al. Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies. J Natl Cancer Inst. 2013;105(12):878–886.
   PubMedGoogle Scholar
• Gondal G, Grotmol T, Hofstad B, et al. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50–64 years. Scand J Gastroenterol. 2003 Jun;38(6):635–642.
   PubMed Web of Science ®Google Scholar
• Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624–1633.
   PubMed Web of Science ®Google Scholar
• Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366(25):2345–2357.
   PubMed Web of Science ®Google Scholar
• Hoff G, Grotmol T, Skovlund E, et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ. 2009;338:b1846.
   PubMedGoogle Scholar
• Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial–SCORE. J Natl Cancer Inst. 2011;103(17):1310–1322.
   PubMedGoogle Scholar
• Holme Ø, Løberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. 2014;312(6):606–615.
   PubMed Web of Science ®Google Scholar
• Müller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med. 1995;123(12):904–910.
   PubMed Web of Science ®Google Scholar
• Kavanagh AM, Giovannucci EL, Fuchs CS, et al. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control. 1998;9(4):455–462.
   PubMed Web of Science ®Google Scholar
• Newcomb PA, Storer BE, Morimoto LM, et al. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst. 2003;95(8):622–625.
   PubMedGoogle Scholar
• Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84(20):1572–1575.
   PubMed Web of Science ®Google Scholar
• Selby JV, Friedman GD, Quesenberry CP Jr, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326(10):653–657.
   PubMed Web of Science ®Google Scholar
• Elmunzer BJ, Hayward RA, Schoenfeld PS, et al. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2012;9(12):e1001352.
   PubMed Web of Science ®Google Scholar
• Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348:g2467.
   PubMed Web of Science ®Google Scholar
• Atkin WS, Cuzick J, Northover JM, et al. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341(8847):736–740.
   PubMed Web of Science ®Google Scholar
• Brenner H, Chang-Claude J, Seiler CM, et al. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011 Jan 4;154(1):22–30.
   PubMed Web of Science ®Google Scholar
• Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369(12):1095–1105.
   PubMed Web of Science ®Google Scholar
• Mulder SA, van Soest EM, Dieleman JP, et al. Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study. Eur J Gastroenterol Hepatol. 2010 Apr;22(4):437–443.
   PubMed Web of Science ®Google Scholar
• Doubeni CA, Weinmann S, Adams K, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013;158(5 Pt 1):312–320.
   PubMed Web of Science ®Google Scholar
• Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009 Jan 6;150(1):1–8. Epub 2008 Dec 15.
   PubMed Web of Science ®Google Scholar
• Brenner H, Chang-Claude J, Jansen L, et al. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology. 2014;146(3):709–717.
   PubMed Web of Science ®Google Scholar
• Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012 Feb 23;366(8):697–706.
   PubMed Web of Science ®Google Scholar
• Rembacken B, Hassan C, Riemann JF, et al. Quality in screening colonoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE). Endoscopy. 2012 Oct;44(10):957–968.
   PubMed Web of Science ®Google Scholar
• Anderson JC, Butterly LF. Colonoscopy: quality Indicators. Clin Transl Gastroenterol. 2015;6(2):e77.
   PubMed Web of Science ®Google Scholar
• Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997 Jan;112(1):24–28. PMID: 8978338.
   PubMed Web of Science ®Google Scholar
• Fireman Z, Kopelman Y. The colon - the latest terrain for capsule endoscopy. Dig Liver Dis. 2007 Oct;39(10):895–899. Epub 2007 Aug 27.
   PubMedGoogle Scholar
• Tran K. Capsule colonoscopy: pillCam Colon. Issues Emerg Health Technol. 2007;Oct(106):1–4.
   Google Scholar
• Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med. 2008;359(12):1207–1217.
   PubMed Web of Science ®Google Scholar
• Whitlock EP, Lin JS, Liles E, et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. preventive services task force. Ann Intern Med. 2008 Nov 4;149(9):638–658. Epub 2008 Oct 6.
   PubMed Web of Science ®Google Scholar
• Walleser S, Griffiths A, Lord SJ, et al. What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation. Clin Gastroenterol Hepatol. 2007 Dec;5(12):1439–1446. quiz 1368.
   PubMed Web of Science ®Google Scholar
• Halligan S, Altman DG, Taylor SA, et al. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology. 2005 Dec;237(3):893–904.
   PubMed Web of Science ®Google Scholar
• Rosman AS, Korsten MA. Meta-analysis comparing CT colonography, air contrast barium enema, and colonoscopy. Am J Med. 2007 Mar;120(3):203–210.e4.
   PubMed Web of Science ®Google Scholar
• Sosna J, Morrin MM, Kruskal JB, et al. CT colonography of colorectal polyps: a meta analysis. AJR Am J Roentgenol. 2003 Dec;181(6):1593–1598.
   PubMed Web of Science ®Google Scholar
• Purkayastha S, Athanasiou T, Tekkis PP, et al. Magnetic resonance colonography vs computed tomography colonography for the diagnosis of colorectal cancer: an indirect comparison. Colorectal Dis. 2007 Feb;9(2):100–111.
   PubMed Web of Science ®Google Scholar
• Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Intern Med. 2005 Apr 19;142(8):635–650.
   PubMed Web of Science ®Google Scholar
• Stoop EM, de Haan MC, de Wijkerslooth TR, et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol. 2012;13:55–64.
   PubMed Web of Science ®Google Scholar
• Sali L, Mascalchi M, Falchini M, et al. Reduced and full-preparation CT colonography, fecal immunochemical test, and colonoscopy for population screening of colorectal cancer: a randomized trial. J Natl Cancer Inst. 2015 Dec 30;108(2):pii: djv319.
   PubMedGoogle Scholar
• Regge D, Iussich G, Segnan N, et al. Comparing CT colonography and flexible sigmoidoscopy: a randomised trial within a population-based screening programme. Gut. 2017 Aug;66(8):1434–1440.
   PubMed Web of Science ®Google Scholar
• Heresbach D, Djabbari M, Riou F, et al. Accuracy of computed tomographic colonography in a nationwide multicentre trial, and its relation to radiologist expertise. Gut. 2011 May;60(5):658–665.
   PubMed Web of Science ®Google Scholar
• Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, et al. Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst. 2010;102(16):1238–1252.
   PubMedGoogle Scholar
• Pickhardt PJ, Kim DH, Meiners RJ, et al. Colorectal and extracolonic cancers detected at screening CT colonography in 10,286 asymptomatic adults. Radiology. 2010 Apr;255(1):83–88.
   PubMed Web of Science ®Google Scholar
• Pooler BD, Kim DH, Pickhardt PJ. Indeterminate but likely unimportant extracolonic findings at screening CT colonography (C-RADS Category E3): incidence and outcomes data from a clinical screening program. AJR Am J Roentgenol. 2016 Nov;207(5):996–1001.
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Hanson ME. Incidental adnexal masses detected at low-dose unenhanced CT in asymptomatic women age 50 and older: implications for clinical management and ovarian cancer screening. Radiology. 2010 Oct;257(1):144–150.
   PubMed Web of Science ®Google Scholar
• Lofton-Day C, Model F, Devos T, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem. 2008;54(2):414–423.
   PubMed Web of Science ®Google Scholar
• Warren JD, Xiong W, Bunker AM, et al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med. 2011 Dec 14;9:133.
   PubMed Web of Science ®Google Scholar
• Lee HS, Hwang SM, Kim TS, et al. Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colon. Transl Oncol. 2013;6(3):290–296.
   PubMed Web of Science ®Google Scholar
• Church TR, Wandell M, Lofton-Day C, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 2014 Feb;63(2):317–325.
   PubMed Web of Science ®Google Scholar
• Gross CP, McAvay GJ, Krumholz HM, et al. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med. 2006;145:646.
   PubMed Web of Science ®Google Scholar
• Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006;42:216.
   PubMed Web of Science ®Google Scholar
• Fuchs CS, Giovannucci EL, Colditz GA, et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med. 1994;331:1669.
   PubMed Web of Science ®Google Scholar
• Ahsan H, Neugut AI, Garbowski GC, et al. Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann Intern Med. 1998;128:900.
   PubMed Web of Science ®Google Scholar
• American Gastroenterological Association. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology. 2001 Jul;121(1):195–197.
   PubMed Web of Science ®Google Scholar
• Vasen HF, Möslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008;57:704.
   PubMed Web of Science ®Google Scholar
• Lynch HT, Smyrk T, McGinn T, et al. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer. 1995;76:2427.
   PubMed Web of Science ®Google Scholar
• Knudsen AL, Bisgaard ML, Bülow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer. 2003;2:43.
   PubMedGoogle Scholar
• Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993;104:1535.
   PubMed Web of Science ®Google Scholar
• Mecklin JP, Järvinen HJ. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer. 1991;68:1109.
   PubMed Web of Science ®Google Scholar
• Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006;296:1507.
   PubMed Web of Science ®Google Scholar
• Møller P, Seppälä TT, Bernstein I, et al. Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the prospective lynch syndrome database. Gut. 2017. DOI:10.1136/gutjnl-2017-314057
   Web of Science ®Google Scholar
• Beggs AD, Latchford AR, Vasen HF, et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010;59:975.
   PubMed Web of Science ®Google Scholar
• Dunlop MG. British Society for Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Guidance on gastrointestinal surveillance for hereditary nonpolyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut. 2002;51(Suppl 5):V21.
   PubMedGoogle Scholar
• Van Assche G, Dignass A, Bokemeyer B, et al. European Crohn’s and Colitis Organisation. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013;7:1–33.
   PubMed Web of Science ®Google Scholar
• Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–535.
   PubMed Web of Science ®Google Scholar
• Jussila A, Virta LJ, Pukkala E, et al. Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland. Scand J Gastroenterol. 2013;48(12):1405–1413.
   PubMed Web of Science ®Google Scholar
• Soetikno RM, Lin OS, Heidenreich PA, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56:48–54.
   PubMed Web of Science ®Google Scholar
• Melville DM, Jass JR, Morson BC, et al. Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol. 1989;20:1008–1014.
   PubMed Web of Science ®Google Scholar
• Claessen MM, Lutgens MW, van Buuren HR, et al. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Inflamm Bowel Dis. 2009;15:1331–1336.
   PubMed Web of Science ®Google Scholar
• Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 1994;107:934–944.
   PubMed Web of Science ®Google Scholar
• Lim CH, Dixon MF, Vail A, et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut. 2003;52:1127–1132.
   PubMed Web of Science ®Google Scholar
• Sinagra E, Tomasello G, Raimondo D, et al. Advanced endoscopic imaging for surveillance for dysplasia and colorectal cancer in inflammatory bowel disease: could the pathologist be further helped? Saudi J Gastroenterol. 2014;20:26–38.
   PubMed Web of Science ®Google Scholar
• Henderson TO, Oeffinger KC, Whitton J, et al. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. Ann Intern Med. 2012;156:757.
   PubMed Web of Science ®Google Scholar
• Nottage K, McFarlane J, Krasin MJ, et al. Secondary colorectal carcinoma after childhood cancer. J Clin Oncol. 2012;30:2552.
   PubMed Web of Science ®Google Scholar
• Corley DA, Jensen CD, Quinn VP, et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA. 2017 Apr 25;317(16):1631–1641. DOI:10.1001/jama.2017.3634
   PubMed Web of Science ®Google Scholar
• O’Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology. 1990;98:371.
   PubMed Web of Science ®Google Scholar
• Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658.
   PubMed Web of Science ®Google Scholar
• Lieberman D, Moravec M, Holub J, et al. Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology. 2008;135:1100.
   PubMed Web of Science ®Google Scholar
• Hassan C, Quintero E, Dumonceau JM, et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2013 Oct;45(10):842–851.
   PubMed Web of Science ®Google Scholar
• Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012;107:13115.
   Web of Science ®Google Scholar
• Weston AP, Campbell DR. Diminutive colonic polyps: histopathology, spatial distribution, concomitant significant lesions, and treatment complications. Am J Gastroenterol. 1995;90:24.
   PubMed Web of Science ®Google Scholar
• Hiraoka S, Kato J, Fujiki S, et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology. 2010;139:1503.
   PubMed Web of Science ®Google Scholar
• Edelstein DL, Axilbund JE, Hylind LM, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut. 2013;62:404.
   PubMed Web of Science ®Google Scholar
• Song SY, Kim YH, Yu MK, et al. Comparison of malignant potential between serrated adenomas and traditional adenomas. J Gastroenterol Hepatol. 2007;22:1786.
   PubMed Web of Science ®Google Scholar
• Bogie R, Sanduleanu S. Optimizing post-polipectomysurveillance: a practical guide for the endoscopist. Dig Endosc. 2016;28:348–359.
   PubMed Web of Science ®Google Scholar
• Currie CJ, Poole CD, Gale EAM. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes,”. Diabetologia. 2009;52(9):1766–1777.
   PubMed Web of Science ®Google Scholar
• Bowker SL, Majumdar SR, Veugelers P, et al. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care. 2006;29(2):254–258.
   PubMed Web of Science ®Google Scholar
• Lin HY, Chin YT, Yang YC, et al. Thyroid hormone, cancer, and apoptosis. Compr Physiol. 2016 Jun 13;6(3):1221–1237.
   PubMed Web of Science ®Google Scholar
• Divella R, De Luca R, Abbate I, et al. Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer. 2016 Nov 26;7(15):2346–2359.
   PubMed Web of Science ®Google Scholar
• Lang M, Gasche C. Chemoprevention of colorectal cancer. Dig Dis. 2015;33:58–67.
   PubMed Web of Science ®Google Scholar
• Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and meta-analysis of observational studies. Am J Gastroenterol. 2005;100:1345–1353.
   PubMed Web of Science ®Google Scholar
• Beaugerie L, Svrcek M, Seksik P, et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology. 2013;145:166–175.
   PubMed Web of Science ®Google Scholar
• Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000;342:1946–1952.
   PubMed Web of Science ®Google Scholar
• Mathers JC, Movahedi M, Macrae F, et al. Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the capp2 randomised controlled trial. Lancet Oncol. 2012;13:1242–1249.
   PubMed Web of Science ®Google Scholar
• Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27:686–693.
   PubMed Web of Science ®Google Scholar
• Park Y, Freedman AN, Gail MH, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol. 2009;27:694–698.
   PubMed Web of Science ®Google Scholar
• Stegeman I, De Wijkerslooth TR, Stoop EM, et al. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut. 2014;63:466–471.
   PubMed Web of Science ®Google Scholar
• Keum N, Aune D, Greenwood DC, et al. Calcium intake and colorectal cancer risk: dose-response meta-analysis of prospective observational studies. Int J Cancer. 2014;135:1940–1948.
   PubMed Web of Science ®Google Scholar
• Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol. 2014;12:478–485.
   PubMed Web of Science ®Google Scholar
• Kaminski MF, Polkowski M, Kraszewska E, et al. A score to estimate the likelihood of detecting advanced colo- rectal neoplasia at colonoscopy. Gut. 2014;63:1112–1119.
   PubMed Web of Science ®Google Scholar
• Chiu HM, Ching JY, Wu KC, et al. A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms. Gastroenterology. 2016 Mar;150(3):617–625.e3.
   PubMed Web of Science ®Google Scholar
• Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011 Sep;60(9):1236–1241.
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Monahan PO, Stump TE, et al. Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study. Ann Intern Med. 2015 Sep 1;163(5):339–346.
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Grossman DC, Curry SJ, et al. US preventive services task force. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315:2564–2575.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Denberg TD, Hopkins RH Jr, et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012;156:378–386.
   PubMed Web of Science ®Google Scholar